- Pfizer Inc PFE COVID-19 Partners BioNTech SE BNTX will configuration Research and production centers in Australia.
- BioNTech and the State of Victoria, Australia, signed a partnership to create a center to conduct clinical research on experimental messenger ribonucleic acid (mRNA), vaccines and therapies.
- The partnership would also include the establishment of mRNA manufacturing facilities in Melbourne.
- As part of this collaboration, the State of Victoria and BioNTech will establish a Research and Innovation Centre, managed in partnership with the State, to support the Australian mRNA ecosystem by curating projects and advancing their potential transition into pre-clinical and clinical development determine, supported by BioNTech advice and know-how.
- The partnership also includes research and development of experimental therapies, including mRNA-based product candidates for indications.
- BioNTech will support the R&D effort on a project basis with the company’s expertise in mRNA research and clinical development of potential new products.
- Price promotion: BNTX shares are down 1.27% to $135.87 on the last check Friday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
